Holen Sie sich die Stockscreener-App
8.16
4.00%
-0.34
Handel nachbörslich:
8.17
0.010
+0.12%
Schlusskurs vom Vortag:
$8.50
Offen:
$8.5
24-Stunden-Volumen:
118.42K
Relative Volume:
0.56
Marktkapitalisierung:
$220.65M
Einnahmen:
$331.52M
Nettoeinkommen (Verlust:
$-52.69M
KGV:
-3.6267
EPS:
-2.25
Netto-Cashflow:
$-14.47M
1W Leistung:
-5.66%
1M Leistung:
-1.92%
6M Leistung:
+15.25%
1J Leistung:
-8.31%
1-Tages-Spanne:
$8.095
$8.50
1-Wochen-Bereich:
$8.095
$8.84
52-Wochen-Spanne:
$5.70
$12.91
Inogen Inc Stock (INGN) Company Profile
Firmenname
Inogen Inc
Sektor
Branche
Telefon
805-562-0500
Adresse
859 WARD DRIVE, GOLETA, CA
Vergleichen Sie INGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
8.16 | 229.84M | 331.52M | -52.69M | -14.47M | -2.25 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Eingeleitet | B. Riley Securities | Buy |
| 2025-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-02-15 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-08-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-07-14 | Herabstufung | Needham | Buy → Hold |
| 2023-01-17 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-12-09 | Hochstufung | Needham | Hold → Buy |
| 2021-11-02 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-12-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-23 | Herabstufung | Needham | Buy → Hold |
| 2020-05-06 | Bestätigt | Needham | Buy |
| 2019-11-06 | Hochstufung | Needham | Hold → Buy |
| 2019-09-13 | Bestätigt | Piper Jaffray | Overweight |
| 2019-08-08 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-08-08 | Herabstufung | Stifel | Buy → Hold |
| 2019-08-07 | Herabstufung | Needham | Buy → Hold |
| 2019-06-28 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-05-08 | Bestätigt | Needham | Strong Buy |
| 2019-02-27 | Bestätigt | Needham | Strong Buy |
| 2018-11-20 | Hochstufung | Needham | Buy → Strong Buy |
| 2018-11-07 | Bestätigt | Needham | Buy |
| 2018-09-10 | Herabstufung | Needham | Strong Buy → Buy |
| 2018-08-22 | Fortgesetzt | Stifel | Buy |
| 2018-08-08 | Bestätigt | Needham | Strong Buy |
| 2018-06-06 | Eingeleitet | KeyBanc Capital Mkts | Sector Weight |
| 2018-05-01 | Bestätigt | Needham | Strong Buy |
| 2018-02-28 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Inogen Inc Aktie (INGN) Neueste Nachrichten
Applying sector rotation models to Inogen Inc.Index Update & Weekly High Return Stock Forecasts - newser.com
Is Inogen Inc. stock ready for a breakoutWeekly Market Outlook & Safe Entry Trade Signal Reports - newser.com
Price momentum metrics for Inogen Inc. explainedPortfolio Value Summary & Fast Exit and Entry Strategy Plans - newser.com
Measuring Inogen Inc.’s beta against major indicesJuly 2025 Analyst Calls & Accurate Intraday Trade Tips - newser.com
Can Inogen Inc. (6IO) stock attract analyst upgradesWeekly Investment Report & AI Enhanced Trade Execution Alerts - newser.com
Inogen Inc. stock retracement – recovery analysisWeekly Gains Summary & Growth Focused Stock Reports - newser.com
How Inogen Inc. stock benefits from strong dollar2025 Top Gainers & Daily Profit Maximizing Tips - newser.com
Building trade automation scripts for Inogen Inc.2025 Fundamental Recap & Weekly High Momentum Picks - newser.com
Technical signs of recovery in Inogen Inc.2025 Performance Recap & Entry Point Strategy Guides - newser.com
How Inogen Inc. (6IO) stock reacts to fiscal policiesWeekly Risk Summary & High Yield Equity Trading Tips - newser.com
Main Clinic Supply Announces Inogen G4 Battery Pack For Portable Oxygen Devices - markets.businessinsider.com
Inogen Rove 4 Mini Portable Oxygen Concentrator: Online Availability Expanded - FinancialContent
United States Portable Oxygen Concentrators Market to hit US$ - openPR.com
Signal strength of Inogen Inc. stock in tech scanners2025 Short Interest & Risk Adjusted Buy and Sell Alerts - newser.com
Real time breakdown of Inogen Inc. stock performanceJuly 2025 Update & Daily Price Action Insights - newser.com
Is this a good reentry point in Inogen Inc.July 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - newser.com
Why Fast-paced Mover Inogen (INGN) Is a Great Choice for Value Investors - Yahoo Finance
Is Inogen Inc a good long term investmentMoving Average Strategies & Rapid Capital Trading Plans - earlytimes.in
Inogen names Naga Rameswamy as CTO - Medical Buyer
Here's Why You Should Retain Inogen Stock in Your Portfolio Now - MSN
Inogen Inc Stock Analysis and ForecastHigh Frequency Trading Trends & Breakthrough Profit Margins - earlytimes.in
What analysts say about Inogen Inc stockEarnings Forecast Updates & Market-Leading Growth Rates - earlytimes.in
Finanzdaten der Inogen Inc-Aktie (INGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Inogen Inc-Aktie (INGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bourque Michael J. | EVP, CFO & Treasurer |
Mar 01 '25 |
Option Exercise |
0.00 |
25,000 |
0 |
25,600 |
| Bourque Michael J. | EVP, CFO & Treasurer |
Mar 03 '25 |
Buy |
8.32 |
3,000 |
24,960 |
47,646 |
| Smith Kevin Raymond Merrill | CEO and President |
Mar 01 '25 |
Option Exercise |
0.00 |
28,333 |
0 |
44,387 |
| Smith Kevin Raymond Merrill | CEO and President |
Mar 03 '25 |
Buy |
8.56 |
11,709 |
100,245 |
70,274 |
| Smith Kevin Raymond Merrill | CEO and President |
Dec 01 '24 |
Option Exercise |
0.00 |
28,333 |
0 |
28,333 |
| Ramade Gregoire | Chief Commercial Officer |
Dec 01 '24 |
Option Exercise |
0.00 |
31,565 |
0 |
31,565 |
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):